BioCentury
ARTICLE | Company News

PerkinElmer, University of Copenhagen deal

June 20, 2005 7:00 AM UTC

The university granted PKI a license to develop assay kits for ADAM12, which is a marker for fetal chromosomal abnormalities, intrauterine growth retardation and preeclampsia. The license is exclusiv...